UK Court Ruling A Blow For Pfizer And A Warning For Patentees

 
• By Ian Schofield

A UK Supreme Court decision to invalidate Pfizer's pregabalin patent is not only bad news for Pfizer and good news for the generics firms involved – it could also mean that companies have to produce more evidence to substantiate their patent claims in future.

Patent law
A UK court decision could have major implications for patent claims. • Source: Shutterstock

More from Legal & IP

More from Pink Sheet